Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (81-90 of 244) with videos related to

Pageof 25
Sort By:
EMBO Reports|January 27, 2023
STING agonism turns human T cells into interferon-producing cells but impedes their functionalityNiklas Kuhl, Andreas Linder, Nora Philipp, et al.
Annals of Hematology|April 6, 2006
Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical courseStephan Oertel, Ralf Ulrich Trappe, Kristin Zeidler, et al.
ACS Chemical Biology|January 11, 2014
Discovery of highly potent p53-MDM2 antagonists and structural basis for anti-acute myeloid leukemia activitiesYijun Huang, Siglinde Wolf, Barbara Beck, et al.
Blood Advances|September 14, 2019
Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesisVictoria V Grunwald, Marcus Hentrich, Xaver Schiel, et al.
Journal of Clinical Medicine|May 1, 2019
Dendritic Cell-Based Immunotherapy of Acute Myeloid LeukemiaHeleen H Van Acker, Maarten Versteven, Felix S Lichtenegger, et al.
Infection|October 4, 2022
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopeniaMichael Ruzicka, Sonja Wurm, Lars Lindner, et al.
Genes, Chromosomes & Cancer|April 19, 2017
A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemiaNadine Sandhöfer, Klaus H Metzeler, Purvi M Kakadia, et al.
Blood|October 23, 2020
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapySemjon Willier, Paula Rothämel, Maximilian Hastreiter, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2024
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case studyMarion Subklewe, Giulia Magno, Christina Gebhardt, et al.
Annals of Neurology|January 13, 2019
Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disordersFranziska S Thaler, Anna L Thaller, Michelle Biljecki, et al.
Pageof 25

Showing results (81-90 of 244) with videos related to

Sort By:
Pageof 25
EMBO Reports|January 27, 2023
STING agonism turns human T cells into interferon-producing cells but impedes their functionalityNiklas Kuhl, Andreas Linder, Nora Philipp, et al.
Annals of Hematology|April 6, 2006
Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical courseStephan Oertel, Ralf Ulrich Trappe, Kristin Zeidler, et al.
ACS Chemical Biology|January 11, 2014
Discovery of highly potent p53-MDM2 antagonists and structural basis for anti-acute myeloid leukemia activitiesYijun Huang, Siglinde Wolf, Barbara Beck, et al.
Blood Advances|September 14, 2019
Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesisVictoria V Grunwald, Marcus Hentrich, Xaver Schiel, et al.
Journal of Clinical Medicine|May 1, 2019
Dendritic Cell-Based Immunotherapy of Acute Myeloid LeukemiaHeleen H Van Acker, Maarten Versteven, Felix S Lichtenegger, et al.
Infection|October 4, 2022
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopeniaMichael Ruzicka, Sonja Wurm, Lars Lindner, et al.
Genes, Chromosomes & Cancer|April 19, 2017
A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemiaNadine Sandhöfer, Klaus H Metzeler, Purvi M Kakadia, et al.
Blood|October 23, 2020
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapySemjon Willier, Paula Rothämel, Maximilian Hastreiter, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2024
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case studyMarion Subklewe, Giulia Magno, Christina Gebhardt, et al.
Annals of Neurology|January 13, 2019
Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disordersFranziska S Thaler, Anna L Thaller, Michelle Biljecki, et al.
Pageof 25